The kinase encoded by PRKACB is involved in tau phosphorylation at Alzheimer’s disease (AD)-related sites, and regulation of this gene has been linked to neuroprotective effects against tau and Aβ-induced toxicity13,14. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.